Comment
. 2007 Sep 1;370(9589):738; author reply 738.
doi: 10.1016/S0140-6736(07)61370-1.
Heparin in sepsis treatment
- PMID: 17765516
- DOI: 10.1016/S0140-6736(07)61370-1
Item in Clipboard
Comment
Heparin in sepsis treatment
Lancet.
.
No abstract available
Comment on
-
Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.Lancet. 2007 Mar 10;369(9564):836-843. doi: 10.1016/S0140-6736(07)60411-5. Lancet. 2007. PMID: 17350452 Clinical Trial.
Similar articles
-
The role of heparin in sepsis: much more than just an anticoagulant.Br J Haematol. 2017 Nov;179(3):389-398. doi: 10.1111/bjh.14885. Epub 2017 Aug 18. Br J Haematol. 2017. PMID: 28832958 Review.
-
Tissue factor pathway inhibitor and antithrombin trial results.Crit Care Clin. 2005 Jul;21(3):433-48. doi: 10.1016/j.ccc.2005.02.002. Crit Care Clin. 2005. PMID: 15992666 Review.
-
Heparin in the treatment of severe sepsis: a new look at an old therapy.Crit Care Med. 2008 Nov;36(11):3098-9. doi: 10.1097/CCM.0b013e31818bdbc6. Crit Care Med. 2008. PMID: 18941311 No abstract available.
-
Anticoagulation in sepsis: is low-dose heparin as effective as activated protein C?Intensive Care Med. 2005 Sep;31(9):1297-8. doi: 10.1007/s00134-005-2723-0. Epub 2005 Jul 9. Intensive Care Med. 2005. PMID: 16007415 No abstract available.
-
What can we learn from the three megatrials using anticoagulants in severe sepsis?Shock. 2004 Dec;22(6):508-12. doi: 10.1097/01.shk.0000145934.24344.64. Shock. 2004. PMID: 15545820 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
